Skip to main content
TipRanks
Go Ultimate75% OFF

BXP (BO9) Stock Price & Analysis

0 Followers

BO9 Stock Chart & Stats

€57.92€0.14(0.24%)
At close: 5:30 PM GMT+1
€50€60€70€80Oct 28Nov 22Oct 25Oct 29Nov 5
Day’s Range
EUR 57.52 - EUR 57.98
52-Week Range
EUR 43.35 - EUR 65.00
Previous Close
EUR 57.78
Volume
N/A
Average Volume (3M)
5
Market Cap
EUR 10.32B
Enterprise Value
EUR 28.20B
Total Cash (Recent Filing)
EUR 1.47B
Total Debt (Recent Filing)
EUR 17.33B
Price to Earnings (P/E)
19.0
Beta
0.65
Next Earnings
Feb 02, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
4.25%

Bulls Say, Bears Say

Bulls Say

Revenue And Earnings Recovery

Steady revenue growth and a rebound in profitability indicate improving underlying earnings power across BXP’s portfolio. Strong EBITDA margins provide operating support, while higher recurring income can strengthen reinvestment capacity and help sustain performance over the next several quarters.

Occupancy And Leasing Momentum

Higher occupancy, substantial leasing volume, and positive rent spreads show that BXP is converting demand into recurring rental income. Continued lease-up of vacant space can lift same-property NOI and improve cash earnings as recently signed leases commence.

Premier Workplace Competitive Position

BXP’s concentration in premier workplaces provides a meaningful market-position advantage, with lower vacancy and substantial rent premiums versus non-premier buildings. Limited new supply and strong demand may support durable occupancy, pricing power, and portfolio resilience.

Bears Say

High Leverage

Heavy leverage and a reduced equity base limit BXP’s financial flexibility and increase sensitivity to operating setbacks or tighter financing conditions. A highly levered balance sheet can constrain acquisitions, development funding, and shareholder distributions during weaker property cycles.

Weaker Cash Conversion

The sharp decline in operating and free cash flow reduces internally generated funding for debt service, development, and distributions. Weaker cash conversion also makes BXP more dependent on asset sales or external financing if operating conditions soften or capital needs rise.

Refinancing And Interest-rate Exposure

Upcoming maturities expose BXP to potentially higher borrowing costs than existing debt, particularly for the GM Building mortgage and Colorado Center financing. Refinancing at higher rates could pressure FFO, reduce cash available for investment, and prolong balance-sheet deleveraging.

BXP News

BO9 FAQ

What was BXP’s price range in the past 12 months?
BXP lowest stock price was €43.35 and its highest was €65.00 in the past 12 months.
What is BXP’s market cap?
BXP’s market cap is €10.32B.
When is BXP’s upcoming earnings report date?
BXP’s next earnings report is estimated for Feb 02, 2027 (not yet confirmed), which is in 77 days.
How were BXP’s earnings last quarter?
BXP released its earnings results on Oct 27, 2026. The company reported €0.642 earnings per share for the quarter, beating the consensus estimate of €0.456 by €0.186.
Is BXP overvalued?
According to Wall Street analysts BXP’s price is currently Undervalued.
Does BXP pay dividends?
BXP does not currently pay dividends.
What is BXP’s EPS estimate?
BXP’s EPS estimate is 0.51.
How many shares outstanding does BXP have?
BXP has 159,672,320 shares outstanding.
What happened to BXP’s price movement after its last earnings report?
BXP reported an EPS of €0.642 in its last earnings report, beating expectations of €0.456. Following the earnings report the stock price went up 0.438%.
Which hedge fund is a major shareholder of BXP?
Hedge funds hold BXP shares: the largest hedge-fund position in BXP is 1,890,804,682 shares, and hedge funds increased their holdings by 6.7M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology